Atlas Trials

Immunogenicity, Efficacy and Safety Trial of the Convacell Vaccine in Healthy Volunteers Aged 18 Years and Older

Clinical trial NCT05726084 · UNKNOWN

Trial details

NCT number
NCT05726084
Sponsor
St. Petersburg Research Institute of Vaccines and Sera
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
COVID-19Coronavirus InfectionsRespiratory Tract InfectionsCOVID-19 Respiratory Infection
Start date
2022-10-24
Primary completion
2023-10-30
Enrollment
16304

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.